OrganOx Appoints Naoya Iwata as CEO & President
OrganOx has appointed Naoya Iwata as its new CEO & President, effective June 1, 2026. With extensive experience at Terumo Corporation, Iwata aims to guide OrganOx during a crucial phase in organ transplantation, leveraging the company’s innovative technologies. He succeeds Craig Marshall and Rupa Basu, who will remain in advisory roles.
OrganOx Appointments Naoya Iwata as CEO & President. Craig Marshall and Rupa Basu will both continue to support OrganOx in advisory roles.